Search Results - "Liao, Kai H."

PK/PD model‐informed dose selection for oncology phase I expansion: Case study based on PF‐06939999, a PRMT5 inhibitor.

Authors: Guo, Cen Liao, Kai H. Li, Meng et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Nov2023, Vol. 12 Issue 11, p1619-1625. 7p.

Bayesian Estimation of Pharmacokinetic and Pharmacodynamic Parameters in a Mode-of-Action-Based Cancer Risk Assessment for Chloroform.

Authors: Liao, Kai H. Tan, Yu‐Mei Conolly, Rory B. et al.

Source: Risk Analysis: An International Journal. Dec2007, Vol. 27 Issue 6, p1535-1551.

Development of a Screening Approach to Interpret Human Biomonitoring Data on Volatile Organic Compounds: Reverse Dosimetry on Biomonitoring Data for Trichloroethylene.

Authors: Liao, Kai H. Tan, Yu‐Mei Clewell, Harvey J.

Source: Risk Analysis: An International Journal. Oct2007, Vol. 27 Issue 5, p1223-1236.

Assessing Kinetic Determinants for Metabolism and Oral Uptake of Octamethylcyclotetrasiloxane (D4) from Inhalation Chamber Studies.

Authors: Dobrev, Ivan D. Nong, Andy Liao, Kai H. et al.

Source: Inhalation Toxicology. Mar2008, Vol. 20 Issue 4, p361-373. 13p. 2 Diagrams, 3 Charts, 8 Graphs.

Dose-Incidence Modeling: Consequences of Linking Quantal Measures of Response to Depletion of Critical Tissue Targets.

Authors: Andersen, Melvin E. Lutz, Roman W. Liao, Kai H. et al.

Source: Toxicological Sciences. Jan2006, Vol. 89 Issue 1, p331-337. 7p.

Bayesian Analysis of A Rat Formaldehyde DNA-Protein Cross-Link Model.

Authors: Yuching Yang Allen, Bruce C. Yu-Mei Tan et al.

Source: Journal of Toxicology & Environmental Health: Part A Jun2010; Vol. 73 (12).

Journal Info: Publisher: Taylor & Francis Ltd ISSN: 1528-7394